Encompass Health Co. (NYSE:EHC) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Encompass Health Co. (NYSE:EHC) have received a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $107.11.

EHC has been the subject of several recent research reports. Barclays boosted their price objective on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Truist Financial reissued a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada upped their price target on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, KeyCorp upped their price target on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th.

Institutional Investors Weigh In On Encompass Health

Large investors have recently made changes to their positions in the stock. TD Private Client Wealth LLC boosted its holdings in shares of Encompass Health by 2,870.0% in the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock valued at $709,000 after buying an additional 7,089 shares during the last quarter. Los Angeles Capital Management LLC boosted its holdings in shares of Encompass Health by 532.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after buying an additional 42,338 shares during the last quarter. Pathstone Holdings LLC raised its stake in Encompass Health by 54.5% in the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock valued at $2,032,000 after acquiring an additional 7,412 shares during the period. Deerfield Management Company L.P. Series C bought a new stake in Encompass Health in the 2nd quarter valued at $541,000. Finally, Meeder Asset Management Inc. raised its stake in Encompass Health by 43.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock valued at $6,417,000 after acquiring an additional 20,242 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Down 0.9 %

Shares of NYSE EHC opened at $95.93 on Friday. The firm’s 50-day simple moving average is $96.58 and its 200 day simple moving average is $94.58. The company has a market cap of $9.66 billion, a price-to-earnings ratio of 23.17, a price-to-earnings-growth ratio of 1.13 and a beta of 0.89. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health has a 12-month low of $70.83 and a 12-month high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.86 EPS. On average, research analysts expect that Encompass Health will post 4.29 earnings per share for the current fiscal year.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.